Zobrazeno 1 - 10
of 687
pro vyhledávání: ''
Publikováno v:
The Journal of Infectious Diseases
A retrospective cohort study was carried out in a large Israeli health maintenance organization to determine vaccine effectiveness (VE) of a third dose of BNT162b2 vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
Autor:
Tanayott Thaweethai, Raymond T. Chung, Andrea S. Foulkes, Zoe Memel, Jenny Jyoung Lee, Patricia P. Bloom
Publikováno v:
medRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
Background Statins may be protective in severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 infection. The aim of the current study was to evaluate the effect of in-hospital statin use on 28-day mortality rates and intensive care unit (ICU) ad
Autor:
Florence Nicolas, Marion Chevandier, Ilse De Coster, Pierre Van Damme, Manon Lambiel, Simonetta Viviani, Paul Willems, Kanchanamala Withanage, Nathalie Cools, Alexandre Le Vert, Jessika Tourneur
Publikováno v:
The journal of infectious diseases
Background OVX836 is a recombinant protein vaccine targeting the highly conserved influenza nucleoprotein (NP), which could confer broad-spectrum protection against this disease. Methods A randomized, placebo-controlled, double-blind, dose-escalating
Publikováno v:
The Journal of Infectious Diseases. 224:S443-S451
This manuscript describes the history, background, and current structure of the United States Immunization Program, founded upon public- and private-sector partnerships that include federal agencies, state and local health departments, tribal nations
Autor:
Krishnarajah Nirantharakumar, Gregory Y.H. Lip, Vanessa Kandoole, Semira Manaseki-Holland, Jingya Wang, Kate Jolly, Deirdre A. Lane, Laura A Benjamin, Mike Gardner, G. Neil Thomas, Henry C. Mwandumba, Tiffany E. Gooden, Stephen Taylor, Isaac B Lwanga
Publikováno v:
The Journal of Infectious Diseases. 225:1348-1356
Background Evidence on the risk of cardiovascular disease (CVD) and CVD risk factors in people with human immunodeficiency virus (PWH) is limited. We aimed to identify the risk of composite CVD, individual CVD events, and common risk factors. Methods
Autor:
Liana R. Andronescu, Julie Gutman, Ankur Markand Sharma, Ingrid Peterson, Jobiba Chinkhumba, Miriam K. Laufer, Martin Kachingwe, Don P. Mathanga, Witness Kachepa, Yuanyuan Liang
Publikováno v:
J Infect Dis
Background Intermittent preventive treatment of malaria during pregnancy (IPTp) with dihydroartemisinin-piperaquine (DP) provides greater protection from placental malaria than sulfadoxine-pyrimethamine (SP). Some studies suggest placental malaria al
Autor:
Gabriel Saiz-Medrano, Rocío Montejano, Julián Nevado, Julen Cadiñanos, María Jiménez-González, Rosa de Miguel, Mario Mayoral-Muñoz, Pilar Barruz, Beatriz Mena-Garay, Berta Rodés, Andrés Esteban-Cantos, Jose R. Arribas, Javier Rodriguez-Centeno, Eulalia Valencia, Jose I Bernardino
Publikováno v:
The Journal of Infectious Diseases. 225:287-294
Background Human immunodeficiency virus (HIV) infection induces epigenetic age acceleration (EAA), but it remains unclear whether epigenetic aging continues to accelerate during successful antiretroviral therapy (ART) and prolonged virological suppre
Autor:
Jade Ghosn, Robert Nzalakanda, Marie-Laure Chaix, Karine Amat, Roland Landman, Constance Delaugerre, Caroline Lascoux-Combe, Minh Patrick Lê, Lambert Assoumou, Gilles Peytavin, Audrey Gabassi, Nadia Valin
Publikováno v:
The Journal of Infectious Diseases. 225:116-120
We compared the proportion of participants achieving first undetectable HIV-1 RNA (VL) in seminal plasma (SP) and blood plasma (BP) in 19 men starting dolutegravir-based regimen at primary HIV infection. At baseline, median VL was 6.5 (interquartile
Publikováno v:
The Journal of Infectious Diseases. 225:146-156
Background Plasmodium vivax controlled human malaria infection (PvCHMI) is an important tool for evaluation of drugs, vaccines, and pathologies associated with this parasite. However, there are few data on safety due to limited numbers of PvCHMIs per
Autor:
Elizabeth R. Unger, Robert A. Bednarczyk, Kristin Vahle, Rayleen M Lewis, Lauri E. Markowitz, Troy D. Querec, Julia W. Gargano
Publikováno v:
The Journal of Infectious Diseases. 225:94-104
Background Apparent associations between human papillomavirus (HPV) prevalence and age observed in cross-sectional studies could be misleading if cohort effects influence HPV detection. Methods Using data from 2003–2016 National Health and Nutritio